Adult stem cells and regenerative medicine-a symposium report
- PMID: 31655007
- PMCID: PMC7135961
- DOI: 10.1111/nyas.14243
Adult stem cells and regenerative medicine-a symposium report
Abstract
Adult stem cells are rare, undifferentiated cells found in all tissues of the body. Although normally kept in a quiescent, nondividing state, these cells can proliferate and differentiate to replace naturally dying cells within their tissue and to repair its wounds in response to injury. Due to their proliferative nature and ability to regenerate tissue, adult stem cells have the potential to treat a variety of degenerative diseases as well as aging. In addition, since stem cells are often thought to be the source of malignant tumors, understanding the mechanisms that keep their proliferative abilities in check can pave the way for new cancer therapies. While adult stem cells have had limited practical and clinical applications to date, several clinical trials of stem cell-based therapies are underway. This report details recent research presented at the New York Academy of Sciences on March 14, 2019 on understanding the factors that regulate stem cell activity and differentiation, with the hope of translating these findings into the clinic.
Keywords: adult stem cells; age-related degeneration; aging; differentiation; epidermal stem cells; hematopoietic stem cells; immune-stem cell interactions; inflammation; lung stem cells; mesenchymal cells; muscle stem cells; regenerative medicine; stem cell niche; stem cell signaling; tissue regeneration; tumor stem cells.
© 2019 New York Academy of Sciences.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
References
-
- National Cancer Institute. 2005. Blood-forming stem cell transplants. September 9, 2005 Accessed April 17, 2019 https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant....
-
- U.S. Food and Drug Administration. 2019. Approved cellular and gene therapy products. May 24, 2019 Accessed August 28, 2019 http://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-produc....
-
- European Medicines Agency. 2018. Holoclar. September 17, 2018 Accessed April 17, 2019 https://www.ema.europa.eu/en/medicines/human/EPAR/holoclar.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
